Found 809 clinical trials
Caregiver Burden and Adaptation of Dementia Relatives During COVID-19
mind, the objectives of this study are: (a) to add to nursing knowledge about the nature and levels of burden among caregivers of relatives with dementia before and during the COVID-19 pandemic, (b) to
- 152 views
- 23 Sep, 2022
- 1 location
- Online study
Parkinson's Progression Markers Initiative Online (PPMI Online)
Parkinson's Progression Markers Initiative Online (PPMI online) is part of the broader Parkinson’s Progression Markers Initiative aimed at better understanding who gets Parkinson’s disease and why. PPMI online is a study collecting participant reported demographic and health information online from people with and without Parkinson’s disease. Once in the study, …
- 162 views
- 14 Sep, 2022
- 1 location
- Online study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Tafasitamab Plus Lenalidomide in Addition to Rituximab Versus Lenalidomide in Addition to Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma Grade 1 to 3a or R/R Marginal Zone Lymphoma (InMIND)
This is a Phase 3 double-blind, placebo-controlled, randomized study designed to investigate whether tafasitamab and lenalidomide as an add-on to rituximab provides improved clinical benefit
- 5 views
- 27 Oct, 2022
- 198 locations
Telerehabilitation Alzheimer's Disease Feasibility (TADF) (TADF)
will all continue with this medication for their 6 months participation. Experimental group will add weekly training on the experimental device, 5 days a week for 12 weeks. Training will
- 1 views
- 31 May, 2022
- 1 location
Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma (TIDE-asthma)
efficacy, safety, and tolerability of add-on therapy with amlitelimab in adult participants with moderate-to-severe asthma. Study details include: The study duration (per participant
- 14 views
- 02 Dec, 2022
- 5 locations
Add on treatment for COPD for patients who experience frequent exacerbations
Current or former smokers who are diagnosed with COPD and experienced at least 2 exacerbations- worsening of symptoms requiring steroid treatment or hospitalization despite being on multiple inhaler medications may qualify for this study involving benralizumab subcutaneous injections compared to placebo injections, initially every 4 weeks, then every 8 weeks …
- 0 views
- 09 Jun, 2022
- 1 location
Add on treatment for Asthma for patients who experience frequent exacerbations
This is a study involving an add-on injectable medication for asthmatic patients who experience frequent exacerbation of their symptoms, requiring additional medications and/or medical care to
- 0 views
- 13 Jul, 2022
- 1 location
A Randomized, Double-Blind, Double Dummy, Parallel Group, Multicenter 24 to 52 Week Variable Length Study to Assess the Efficacy and Safety of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered Dose Inhaler (MDI) Relative to Budesonide and Formoterol Fumarate MDI and Symbicort® Pressurized MDI in Adult and Adolescent Participants with Inadequately Controlled Asthma (KALOS)
Add-on medication for patients with poorly controlled asthma requiring frequent hospitalization or steroid treatment to control asthma symptoms, despite being on regular asthma controller
- 5 views
- 28 Jun, 2022
- 1 location
Hypertension
The purpose of this study is to evaluate the effect of zilebesiran on systolic and diastolic blood pressure and to characterize the pharmacodynamic (PD) effects and safety of zilebesiran as add
- 0 views
- 18 Apr, 2022
- 1 location
Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)
Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)
- 271 views
- 23 Nov, 2020
- 1 location